{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:31:00Z","timestamp":1762918260839,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012351","name":"Mitsubishi Tanabe Pharma Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012351","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP17ek0210082"],"award-info":[{"award-number":["JP17ek0210082"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ijcha.2021.100883","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T08:02:20Z","timestamp":1632902540000},"page":"100883","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Identifying risk patterns in older adults with atrial fibrillation by hierarchical cluster analysis: A retrospective approach based on the risk probability for clinical events"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4769-5925","authenticated-orcid":false,"given":"Shinya","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuto","family":"Arita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoharu","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikio","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Semba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroto","family":"Kano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Matsuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tokuhisa","family":"Uejima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Oikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Matsuhama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4065-7579","authenticated-orcid":false,"given":"Mitsuru","family":"Iida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Yajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcha.2021.100883_b0005","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/europace\/euz141","article-title":"Prevalence of atrial fibrillation in the Italian elderly population and projections from 2020 to 2060 for Italy and the European Union: the FAI Project","volume":"21","author":"Di Carlo","year":"2019","journal-title":"Europace"},{"issue":"9","key":"10.1016\/j.ijcha.2021.100883_b0010","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s40266-017-0477-3","article-title":"Underuse of oral anticoagulants and inappropriate prescription of antiplatelet therapy in older inpatients with atrial fibrillation","volume":"34","author":"Averlant","year":"2017","journal-title":"Drugs Aging"},{"issue":"11","key":"10.1016\/j.ijcha.2021.100883_b0015","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s40266-017-0493-3","article-title":"Underuse of anticoagulation in older patients with atrial fibrillation and CHADS(2) score \u2265 2: are we doing better since the marketing of direct oral anticoagulants?","volume":"34","author":"Henrard","year":"2017","journal-title":"Drugs Aging"},{"issue":"8","key":"10.1016\/j.ijcha.2021.100883_b0020","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jacc.2009.11.040","article-title":"Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis","volume":"55","author":"de Vos","year":"2010","journal-title":"J Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcha.2021.100883_b0025","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.ijcha.2021.100883_b0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ebiom.2017.03.046","article-title":"Biological age predictors","volume":"21","author":"Jylh\u00e4v\u00e4","year":"2017","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.ijcha.2021.100883_b0035","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/jamacardio.2017.4665","article-title":"Association of of atrial fibrillation clinical phenotypes with treatment patterns and outcomes: a multicenter registry study","volume":"3","author":"Inohara","year":"2018","journal-title":"JAMA Cardiol."},{"issue":"6","key":"10.1016\/j.ijcha.2021.100883_b0040","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.amjcard.2019.05.071","article-title":"A cluster analysis of the Japanese multicenter outpatient registry of patients with atrial fibrillation","volume":"124","author":"Inohara","year":"2019","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcha.2021.100883_b0045","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1186\/s12913-020-05668-7","article-title":"Tailoring integrated care services for high-risk patients with multiple chronic conditions: a risk stratification approach using cluster analysis","volume":"20","author":"Bretos-Azcona","year":"2020","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.ijcha.2021.100883_b0050","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1253\/circj.CJ-15-1237","article-title":"Nine-year trend of anticoagulation use, thromboembolic events, and major bleeding in patients with non-valvular atrial fibrillation-Shinken database analysis","volume":"80","author":"Suzuki","year":"2016","journal-title":"Circ. J."},{"issue":"301","key":"10.1016\/j.ijcha.2021.100883_b0055","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/01621459.1963.10500845","article-title":"Hierarchical grouping to optimize an objective function","volume":"58","author":"Ward","year":"1963","journal-title":"J. Am. Statist. Assoc."},{"key":"10.1016\/j.ijcha.2021.100883_b0060","first-page":"1","article-title":"A dendrite method for cluster analysis","volume":"3","author":"Cali\u0144ski","year":"1974","journal-title":"Commun. Statist."},{"issue":"23","key":"10.1016\/j.ijcha.2021.100883_b0065","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1136\/heartjnl-2016-309741","article-title":"Stroke and death in elderly patients with atrial fibrillation in Japan compared with the United Kingdom","volume":"102","author":"Senoo","year":"2016","journal-title":"Heart"},{"issue":"7","key":"10.1016\/j.ijcha.2021.100883_b0070","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005657","article-title":"Thromboembolic risk, bleeding outcomes and effect of different antithrombotic strategies in very elderly patients with atrial fibrillation: a sub-analysis from the PREFER in AF (PREvention oF thromboembolic events-European registry in atrial fibrillation)","volume":"6","author":"Patti","year":"2017","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.ijcha.2021.100883_b0075","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCULATIONAHA.113.005008","volume":"130","author":"Halperin","year":"2014","journal-title":"Circulation"},{"issue":"28","key":"10.1016\/j.ijcha.2021.100883_b0080","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1093\/eurheartj\/ehu046","article-title":"Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial","volume":"35","author":"Halvorsen","year":"2014","journal-title":"Eur Heart J."},{"issue":"5","key":"10.1016\/j.ijcha.2021.100883_b0085","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003432","article-title":"Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial","volume":"5","author":"Kato","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcha.2021.100883_b0090","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1093\/eurheartj\/ehy411","article-title":"A 10 year study of hospitalized atrial fibrillation-related stroke in England and its association with uptake of oral anticoagulation","volume":"39","author":"Cowan","year":"2018","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.ijcha.2021.100883_b0095","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1253\/circj.CJ-19-0094","article-title":"Baseline demographics and clinical characteristics in the all Nippon AF in the elderly (ANAFIE) registry","volume":"83","author":"Koretsune","year":"2019","journal-title":"Circ. J."},{"issue":"10","key":"10.1016\/j.ijcha.2021.100883_b0100","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1253\/circrep.CR-20-0082","article-title":"Oral anticoagulant use in elderly japanese patients with non-valvular atrial fibrillation \u2013 subanalysis of the ANAFIE registry","volume":"2","author":"Akao","year":"2020","journal-title":"Circul. Rep."},{"issue":"1","key":"10.1016\/j.ijcha.2021.100883_b0105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jjcc.2020.01.010","article-title":"Rhythm versus rate control strategies regarding anticoagulant use in elderly non-valvular atrial fibrillation patients: Subanalysis of the ANAFIE (All Nippon AF In the Elderly) Registry","volume":"76","author":"Yuzawa","year":"2020","journal-title":"J Cardiol."},{"key":"10.1016\/j.ijcha.2021.100883_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jjcc.2020.06.015","article-title":"Characteristics and anticoagulant treatment status of elderly non-valvular atrial fibrillation patients with a history of catheter ablation in Japan: Subanalysis of the ANAFIE registry","author":"Okumura","year":"2020","journal-title":"J. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcha.2021.100883_b0115","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1016\/j.ijcard.2013.07.234","article-title":"A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study","volume":"168","author":"Potpara","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcha.2021.100883_b0120","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/clc.23294","article-title":"A multicenter prospective cohort study to investigate the effectiveness and safety of apixaban in Japanese elderly atrial fibrillation patients (J-ELD AF Registry)","volume":"43","author":"Okumura","year":"2020","journal-title":"Clin. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcha.2021.100883_b0125","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s11739-015-1226-4","article-title":"Direct oral anticoagulants in the secondary prevention of stroke and transient ischemic attack in patients with atrial fibrillation","volume":"10","author":"Arnao","year":"2015","journal-title":"Int. Emerg. Med."},{"issue":"2","key":"10.1016\/j.ijcha.2021.100883_b0130","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.amjcard.2016.04.039","article-title":"Long-term population-based cerebral ischemic event and cognitive outcomes of direct oral anticoagulants compared with warfarin among long-term anticoagulated patients for atrial fibrillation","volume":"118","author":"Jacobs","year":"2016","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcha.2021.100883_b0135","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehz782","article-title":"Cabins, castles, and constant hearts: rhythm control therapy in patients with atrial fibrillation","volume":"40","author":"Willems","year":"2019","journal-title":"Eur. Heart J."},{"issue":"18","key":"10.1016\/j.ijcha.2021.100883_b0140","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1056\/NEJMoa2012883","article-title":"Low-dose edoxaban in very elderly patients with atrial fibrillation","volume":"383","author":"Okumura","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.ijcha.2021.100883_b0145","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1161\/CIRCULATIONAHA.120.050991","article-title":"Ablation versus drug therapy for atrial fibrillation in heart failure: results from the CABANA trial","volume":"143","author":"Packer","year":"2021","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ijcha.2021.100883_b0150","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/j.hrthm.2015.07.003","article-title":"Prospective, multicenter validation of a clinical risk score for left atrial arrhythmogenic substrate based on voltage analysis: DR-FLASH score","volume":"12","author":"Kosiuk","year":"2015","journal-title":"Heart Rhythm."},{"issue":"10","key":"10.1016\/j.ijcha.2021.100883_b0155","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00392-015-0856-x","article-title":"The APPLE score: a novel and simple score for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation","volume":"104","author":"Kornej","year":"2015","journal-title":"Clin. Res. Cardiol."},{"issue":"11","key":"10.1016\/j.ijcha.2021.100883_b0160","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.hrthm.2016.07.018","article-title":"Predicting atrial fibrillation ablation outcome: the CAAP-AF score","volume":"13","author":"Winkle","year":"2016","journal-title":"Heart Rhythm."},{"issue":"6","key":"10.1016\/j.ijcha.2021.100883_b0165","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/joa3.12429","article-title":"A novel and simple scoring system for assessing the indication for catheter ablation in patients with atrial fibrillation: the HEAL-AF Score","volume":"36","author":"Otsuka","year":"2020","journal-title":"J. Arrhythmia."},{"issue":"22","key":"10.1016\/j.ijcha.2021.100883_b0170","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ijcha.2021.100883_b0175","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d124","article-title":"Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study","volume":"342","author":"Olesen","year":"2011","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.ijcha.2021.100883_b0180","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1253\/circj.CJ-20-1075","article-title":"A novel risk stratification system for ischemic stroke in japanese patients with non-valvular atrial fibrillation","volume":"85","author":"Okumura","year":"2021","journal-title":"Circ. J."}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906721001718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906721001718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T05:12:22Z","timestamp":1762492342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906721001718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":36,"alternative-id":["S2352906721001718"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2021.100883","relation":{},"ISSN":["2352-9067"],"issn-type":[{"type":"print","value":"2352-9067"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identifying risk patterns in older adults with atrial fibrillation by hierarchical cluster analysis: A retrospective approach based on the risk probability for clinical events","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2021.100883","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100883"}}